What to Expect When Starting Digoxin
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Introduction
Digoxin is a cardiac glycoside derived from the foxglove plant, used to treat heart failure and control heart rate in atrial fibrillation. It strengthens heart contractions and slows electrical conduction through the AV node. Digoxin has a very narrow therapeutic window — the difference between an effective dose and a toxic dose is small — making regular blood level monitoring essential.
Week-by-week timeline
Loading and Initial Dosing
Digoxin may be started with a loading dose (digitalization) for rapid effect, or at a maintenance dose for gradual accumulation. Effects on heart rate in AFib may be noticeable within hours of a loading dose. Nausea, loss of appetite, and visual disturbances (yellow-green halos, blurred vision) in the first days may be signs of toxicity even at low doses.
First Blood Level Check
A digoxin serum level is typically checked 5-7 days after starting (or sooner if toxicity is suspected). The target therapeutic range is 0.5-0.9 ng/mL for heart failure and 0.8-2.0 ng/mL for rate control in AFib. Levels above 2.0 ng/mL are associated with significant toxicity risk.
Dose Refinement
Based on blood levels, kidney function, and clinical response, the dose may be adjusted. Digoxin is primarily cleared by the kidneys — any change in kidney function directly affects blood levels. Many medications interact with digoxin, altering its levels.
Stable Monitoring Phase
Once on a stable dose, digoxin levels and kidney function are monitored periodically (every 3-6 months). Electrolytes — especially potassium and magnesium — must be kept in the normal range, as low potassium dramatically increases digoxin toxicity risk.
Long-Term Management
Digoxin does not reduce mortality in heart failure but reduces hospitalizations and improves symptoms. In AFib, it controls resting heart rate well but is less effective during exercise. Long-term use requires diligent monitoring of levels, kidney function, and electrolytes.
When to call your doctor
Contact your healthcare provider if you experience:
- Nausea, vomiting, or loss of appetite (early toxicity signs — check digoxin level)
- Visual disturbances: yellow-green halos around lights, blurred vision, or seeing colors differently (classic digoxin toxicity signs)
- Slow or irregular heart rate (bradycardia or arrhythmia)
- Palpitations or rapid irregular heartbeat (digoxin-induced arrhythmias)
- Confusion, dizziness, or fainting
- Severe weakness or fatigue
- Symptoms of low potassium: muscle cramps, weakness (hypokalemia worsens digoxin toxicity)
Tips for getting started
Monitor your pulse daily at the same time — if below 60 beats per minute (or per your doctor's instructions), hold the dose and call your prescriber. Never double doses if you miss one. Maintain adequate potassium and magnesium intake — low levels dramatically increase toxicity risk. Avoid salt substitutes without consulting your doctor (may alter potassium). Report nausea, vision changes, or irregular heart rhythm immediately — these can be early toxicity signs. Bring a complete medication list to every appointment — many drugs alter digoxin levels. If you use antacids, take them 2 hours apart from digoxin.
Frequently asked questions
More about Digoxin
References
- [Regulatory] FDA Label: Lanoxin (digoxin) Tablets https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020405s011lbl.pdf Accessed 2026-03-01.
- [Regulatory] NIH MedlinePlus: Digoxin https://medlineplus.gov/druginfo/meds/a682301.html Accessed 2026-03-01.
- [Regulatory] ACC/AHA Heart Failure Guidelines: Digoxin https://www.jacc.org/doi/10.1016/j.jacc.2021.12.012 Accessed 2026-03-01.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: